Covid-19: With no prospects for profits, big pharma neglects new infectious diseases
By Jessica Davis Plüss http://www.swissinfo.ch More companies, including some big Swiss drugmakers, are shifting resources away from emerging infectious diseases into more lucrative areas like cancer treatment. Their […]